Open-access Charles Bonnet Syndrome: Case series

Síndrome de Charles Bonnet: casuística

Abstract

Since its first description in 1760, Charles Bonnet syndrome (CBS) has been reported in many studies. The main characteristics are visual hallucinations, preserved awareness of unreal visions, and absence of psychotic symptoms. CBS can occur with lesions located anywhere along the central visual pathway, from the eye to the calcarine fissure.

Objective:  To describe patients with CBS and carry out a review of the literature.

Methods:  Six patients with visual hallucinations were evaluated in an outpatient memory clinic between 2001 and 2008, and their clinical characteristics recorded.

Results:  Four patients were female, and the mean age was 74.5±16.9 years. Three patients had visual loss secondary to eye disease and three due to cerebral lesions. The visions consisted of animals, persons, moving objects, bizarre creatures or colored forms, and were considered disturbing by five patients. Five patients received treatment, and only three reported partial benefit from the therapy. Complete recovery was not seen in any of the subjects.

Conclusions:  CBS is relatively rare and its recognition is important to avoid misdiagnoses with psychiatric or dementing illnesses.

Key words: Charles Bonnet syndrome; visual hallucinations; visual loss.

Resumo

Desde sua descrição em 1760, a Síndrome de Charles Bonnet (SCB) tem sido relatada em vários estudos. Suas características centrais são: alucinações visuais, consciência preservada sobre as alucinações e ausência de sintomas psicóticos. SCB pode ocorrer com lesões desde o olho até o córtex calcarino.

Objetivo:  Descrever pacientes com SCB e fornecer revisão da literatura.

Métodos:  Seis pacientes com alucinações visuais foram avaliados em um ambulatório de memória no período de 2001 a 2008 e suas características foram descritas.

Resultados:  Quatro pacientes eram do sexo feminino, e a idade média foi de 74,5±16,9 anos. Três dos pacientes apresentavam perda visual secundária a lesões oculares e três devido a lesões cerebrais levando a comprometimento visual. O conteúdo das visões consistia de animais, pessoas, objetos em movimento, criaturas bizarras ou formas coloridas. Cinco pacientes receberam tratamento, e apenas três relataram benefício parcial. Melhora completa não foi observada.

Conclusões:  SCB é relativamente rara e seu reconhecimento é importante para evitar erros diagnósticos com doenças psiquiátricas ou quadros demenciais.

Palavras-chave: síndrome de Charles Bonnet; alucinações visuais; perda visual.

Texto completo disponível apenas em PDF.

Full text available only in PDF format.

References

  • 1 Damas-Mora J, Skelton-Robinson M, Jenner FA. The Charles Bonnet syndrome in perspective. Psychol Med 1982;12: 251-261.
  • 2 DeMorsier G. The Charles Bonnet syndrome: visual hallucinations in the aged without mental deficiency. Ann Med Psychol (Paris) 1967;2:678-702.
  • 3 Bonnet C. Essai analytique sur les aculties de l'ame. Copenhagen: Ferres & Philibert; 1760: 426-429.
  • 4 Ffytche DH, Howard RJ. The perceptual consequences of visual loss: "positive" pathologies of vision. Brain 1999;122:1247-1260.
  • 5 Norton-Willson L, Munir M. Visual perceptual disorders resembling the Charles Bonnet syndrome: a study of 434 consecutive patients referred to a psychogeriatric unit. Fam Pract 1987;4: 27-31.
  • 6 Brown GC, Murphy RP. Visual symptoms associated with choroidal neovascularization: photopsias and the Charles Bonnet syndrome. Arch Ophthalmol 1992;110:1251-1256.
  • 7 Teunisse RJ, Cruysberg JRM, Verbeek A, Zitman FG. The Charles Bonnet syndrome: a large prospective study in Netherlands. Brit J Psychiatry 1995; 166: 254-257.
  • 8 Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996;347:794-797.
  • 9 Adachi N. Charles Bonnet syndrome in leprosy: prevalence and clinical characteristics. Acta Psychiatr Scand 1996;93:279-281.
  • 10 O'Reilly R, Chamberlaine C. Charles Bonnet syndrome: incidence and demographic and clinical features. Can J Psychiatry 1996;41:259-260.
  • 11 Nesher R, Nesher G, Epstien E, Assia E. Charles Bonnet Syndrome in glaucoma with low vision. J Glaucoma 2001;10:396-400.
  • 12 Shiraishi Y, Terao T, Nakamura J, Tawara A. The rarity of Charles Bonnet Syndrome. J Psychiatr Res 2004;38:207-213.
  • 13 Vukicevic M, Fitzmaurice K. Butterflies and black lacy patterns: the prevalence and characteristics of Charles Bonnet hallucinations in an Australian population. Clin Experiment Ophthalmol 2008;36:659-665.
  • 14 Khan JC, Shadid H, Thurlby DA, Yates JR, Moore AT. Charles Bonnet syndrome in age-related macular degeneration: the nature and frequency of images in subjects with end-stage disease. Ophthalmic Epidemiol 2008;15:202-208.
  • 15 Schwartz TL, Vahgei L. Charles Bonnet syndrome in children. J AAPOS 1998;2: 310-313.
  • 16 Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Sugestões para o uso do mini-exame do estado mental no Brasil. Arq Neuropsiquiatr 2003; 61:777-81.
  • 17 Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: the Charles Bonnet syndrome. Surv Ophthalmol 2003;48:58-72.
  • 18 Teunisse RJ, Cruysberg JR, Hoefnagels WH, Kuin Y, Verbeek AL, Zitman FG. Social and psychological characteristics of elderly visually handicapped patients with the Charles Bonnet Syndrome. Compr Psychiatry 1999;40:315-319.
  • 19 Santhouse AM, Howard RJ, ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain 2000;123:2055-2064.
  • 20 Cogan DG. Visual hallucinations as release phenomena. Arch Klin Exp Ophthalmol 1973;188:139-150.
  • 21 Adachi N, Watanabe T, Matsuda H, Onuma T. Hyperperfusion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in patients with Charles Bonnet syndrome. Psychiatry Clin Neurosci 2000;54:157-162.
  • 22 Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry 2002;73:535-541.
  • 23 Freiman TM, Surges R, Vougioukas VI et al. Complex visual hallucinations (Charles Bonnet syndrome) in visual field defects following cerebral surgery. J Neurosurg 2004;101:846-853.
  • 24 Plummer C, Kleinitz A, Vroomen P, Watts R. Of Roman chariots and goats in overcoats: the Syndrome of Charles Bonnet. J Clin Neurosc 2007;14:709-714.
  • 25 Villa FJ. The Charles Bonnet Syndrome. An R Acad Nac Med (Madr) 2008;125: 387-395.
  • 26 Qu Y, Eysel UT, Vandesande F, Arckens L. Effect of partial sensory deprivation on monoaminergic neuromodulators in striate cortex of adult cat. Neuroscience 2000;101:863-868.
  • 27 Seeburg DP, Liu X, Chen C. Frequency-dependent modulation of retinogeniculate transmission by serotonin. J Neurosci 2004;24:10950-10962.
  • 28 Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998;121:1819-1840.
  • 29 Görgens K, Liedtke M. Charles Bonnet syndrome. Psychiatr Prax 1998; 25: 85-86.
  • 30 Hori H, Terao T, Shiraishi Y. Treatment of Charles Bonnet syndrome with valproate. Int Clin Psychopharmacol 2000; 15:117-119.
  • 31 Paulig M, Mentrup H. Charles Bonnet syndrome: complete remission of complex visual hallucinations treated by gabapentin. J Neurol Neurosurg Psychiatry 2001;70: 813-814.
  • 32 Valencia C, Franco JG. Charles Bonnet syndrome: report of one case managed with haloperidol. Rev Med Chil 2008;136:347-350.
  • 33 Maeda K, Shirayama Y, Nukina S, Yoshioka S, Kawahara R. Charles Bonnet syndrome with visual hallucinations of childhood experience: successful treatment of 1 patient with risperidone. J Clin Psychiatry 2003;64:1131-1132.
  • 34 Alao AO; Hanrahan B. Charles Bonnet syndrome: visual hallucination and multiple sclerosis. Int J Psychiatry Med 2003;33:195-199.
  • 35 Lang UE, Stogowski D, Schulze D et al. Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. J Psychopharmacol 2007;21:553-555.
  • 36 Siddiqui E, Ramaswamay S, Petty F. Mirtazapine for Charles Bonnet syndrome. Can J Psychiatry 2004;49:787-788.
  • 37 Ukai S, Yamamoto M, Tanaka M, Takeda M. Treatment of typical Charles Bonnet syndrome with donepezil. Int Clin Psychopharmacol 2004;19:355-357.
  • 38 Ranen NG, Pasternak RE, Rovner BW. Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. Am J Geriatr Psychiatry 1999;7: 264-265.
  • 39 Pliskin NH, Kiolbasa TA, Towle VL et al. Charles Bonnet Syndrome: an early marker for dementia ? J Am Geriatr Soc 1996;44:1055-1061.
  • 40 Donoso SA, Silva RC, Fuentes GP, Gaete CG. Síndrome de Charles Bonnet: presentación de tres casos y revisión de la literatura. Rev Med Chile 2007; 135:1034-1039.
  • 41 Cortizo V, Rosa AAM, Soriano DS, Takada LT, Nitrini R. Charles Bonnet syndrome: visual hallucinations in patients with ocular diseases- case report. Arq Bras Oftalmol 2005;68: 129-132.
  • 42 Meyer CH, Mennel S, Hörle S, Schmidt JC. Visual hallucinations after intravitreal injection of bevacizumab in vascular age-related macular degeneration. Am J Ophthalmol 2007;143:169-170.
  • 43 Tan CS, Sabel BA, Eong KG. Charles Bonnet syndrome (visual hallucinations) following enucleation. Eye 2006;20: 1394-1395.
  • 44 Tan CS, Sabel BA, Goh KY. Visual hallucinations during visual recovery after central retinal artery occlusion. Arch Neurol 2006;63:598-600.
  • 45 Lepore FE. Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways. Neurology 1990;40:444-447.
  • 46 Cole M. When the left brain is not right the right brain may be left: report of personal experience of occipital hemianopia. J Neurol Neurosurg Psychiatry 1999; 67:169-173.
  • 47 Choi EJ, Lee JK, Kang JK, Lee SA. Complex visual hallucinations after occipital cortical resection in a patient with epilepsy due to cortical dysplasia. Arch Neurol 2005;62:481-484.
  • 48 McNamara ME, Heros RC, Boller F. Visual hallucinations in blindness: the Charles Bonnet syndrome. Int J neurosci 1982;17:13-15.
  • 49 Razavi M, Jones RD, Manzel K, Fattal D, Rizzo M. Steroid-responsive Charles Bonnet syndrome in temporal arteritis. J Neuropsychiatry Clin Neurosci 2004;16: 505-508.

Publication Dates

  • Publication in this collection
    Jan-Mar 2009

History

  • Received
    29 Jan 2009
  • Accepted
    25 Feb 2009
location_on
Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento R. Vergueiro, 1353 sl.1404 - Ed. Top Towers Offices, Torre Norte, São Paulo, SP, Brazil, CEP 04101-000, Tel.: +55 11 5084-9463 | +55 11 5083-3876 - São Paulo - SP - Brazil
E-mail: revistadementia@abneuro.org.br | demneuropsy@uol.com.br
rss_feed Stay informed of issues for this journal through your RSS reader
Accessibility / Report Error